日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Advances in Targeting HER2 across Cancer Subtypes: A Pan-Tumor Approach

针对HER2靶向治疗癌症亚型的进展:一种泛肿瘤方法

Adesoye, Taiwo; Dumbrava, Ecaterina E; Raghav, Kanwal P S; Sahin, Aysegul A; Chen, Hui; Lee, Sunyoung S; Javle, Milind M; Pant, Shubham; Alhalabi, Omar; Le, Xiuning; Valero, Vicente; Pohlmann, Paula R; Meric-Bernstam, Funda

MAPK Pathway Mutations Emerge in Mutant IDH1 Inhibitor-Resistant Cholangiocarcinoma and Attenuate the IFN Response

MAPK通路突变出现在对IDH1抑制剂耐药的胆管癌中,并减弱IFN反应

Wan, Jinkai; Saatcioglu, Hatice Duygu; Ellis, Haley; Aguado-Fraile, Elia; Xu, Qin; Kondo, Hiroshi; Manguso, Robert T; Gritti, Ilaria; Norden, Bryanna L; Noble, Carolina; Corcoran, Ryan B; Lubner, Sam J; Javle, Milind; Abou-Alfa, Ghassan K; Cleary, James M; Kelley, Robin K; Borad, Mitesh J; Macarulla, Teresa; Oh, Do Youn; Daigle, Scott; Gliser, Camelia; Pandya, Susan; Choe, Sung; Tron, Adriana E; Bardeesy, Nabeel

Phase III trial of infigratinib versus gemcitabine/cisplatin in adults with advanced cholangiocarcinoma with FGFR2 gene fusion or rearrangement: results and reflections on early termination of PROOF 301

一项针对伴有FGFR2基因融合或重排的晚期胆管癌成人患者的III期临床试验:英菲格替尼对比吉西他滨/顺铂方案的疗效:PROOF 301试验的结果及提前终止的反思

Abou-Alfa, G K; Borbath, I; Roychowdhury, S; Goyal, L; Lamarca, A; Macarulla, T; Shroff, R T; Oh, D-Y; Tamaş, C; Savastano, D M; van Veenhuyzen, D F; Xu, C; Freas, E; Solanas, J; Javle, M M

Broadening the gates: Analysis of potentially modifiable study entry criteria in pancreatic and biliary tract cancer trials

拓宽入组门槛:胰腺癌和胆道癌试验中潜在可修改的研究入组标准分析

Saj, Fen; Namayanja, Felicity K; Xiao, Lianchun; Borad, Mitesh J; Kelley, Robin Kate; Goyal, Lipika; Azad, Nilofer S; Bachini, Melinda; Lindsey, Stacie; Pant, Shubham; Valle, Juan W; Fashoyin-Aje, Lola A; Javle, Milind

Actionable genomic landscape of biliary tract cancer in the Indian population

印度人群胆道癌的可操作基因组图谱

Limaye, Sewanti; Shreenivas, Aditya; Patil, Darshana; Vyas, Soumil; George, Irene A; Sambath, Janani; Singh, Shambhavi; Madre, Chetan; Parab, Anjali; Kataria, Pritam; Shah, Darshit; Shah, Niyati; Dawood, Shaheenah; Rohatgi, Nitesh; Deshpande, Ruturaj; Datta, Aakriti; Shamsi, Humaid Al; Gaya, Andrew; Vaid, Ashok Kumar; Kulkarni, Shriniwas; Rajappa, Senthil; Rieke, Damian; Kumar, Prashant; Datar, Rajan; Javle, Milind

Clinicogenomic and Histopathologic Analyses of Supermassive Intrahepatic Cholangiocarcinoma and the Role of Ablative Radiotherapy

超巨大肝内胆管癌的临床基因组学和组织病理学分析及消融放射治疗的作用

Abi Jaoude, Joseph; Lau, Alexandria; Yuan, Yinyin; Meimoun, Noah S; De, Brian; Liao, Kaiping; Kouzy, Ramez; Nieves-Jimenez, Humberto R; Poenisch, Falk; Balter, Peter A; Brock, Kristy K; Sawakuchi, Gabriel O; Vauthey, Jean-Nicolas; Tzeng, Ching-Wei D; Shamsutdinova, Diana; Lazar, Alexander J; Chatterjee, Deyali; Holliday, Emma B; Smith, Grace L; Minsky, Bruce D; Das, Prajnan; Koong, Albert C; Lee, Sunyoung S; Tran Cao, Hop S; Javle, Milind; Kwong, Lawrence; Koay, Eugene J; Ludmir, Ethan B

Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer

利用患者来源的异种移植模型建立胆道癌精准肿瘤学模型

Timothy P DiPeri, Kurt W Evans, Stephen Scott, Xiaofeng Zheng, Kaushik Varadarajan, Lawrence N Kwong, Michael Kahle, Hop S Tran Cao, Ching-Wei Tzeng, Thuy Vu, Sunhee Kim, Fei Su, Maria Gabriela Raso, Yasmeen Rizvi, Ming Zhao, Huamin Wang, Sunyoung S Lee, Timothy A Yap, Jordi Rodon, Milind Javle, Fun

Poly(adenosine diphosphate ribose) polymerase inhibition in isocitrate dehydrogenase 1 and 2-mutant tumors: Bridging science with the clinic

异柠檬酸脱氢酶1和2突变肿瘤中聚腺苷二磷酸核糖聚合酶的抑制:连接科学与临床

Nassif Haddad, Elise; Javle, Milind M; Yap, Timothy A

A phase I/II trial of avelumab combinations with ivuxolimab, utomilumab, and radiation therapy in patients with advanced gastrointestinal malignancies

一项针对晚期胃肠道恶性肿瘤患者的阿维鲁单抗联合伊伐沙利单抗、乌托米鲁单抗和放射疗法的I/II期试验

Ahmed, Jibran; Knisely, Anne; Torrado, Carlos; Stephen, Bettzy; Yang, Yali; Song, Juhee; Alshawa, Anas; Zarifa, Abdulrazzak; Jhingran, Anuja; Koay, Eugene J; Morris, Van Karlyle; Javle, Milind; Wolff, Robert A; Meric-Bernstam, Funda; Pant, Shubham; Rodon, Jordi; Naing, Aung

Economic and clinical outcomes among patients with cholangiocarcinoma receiving pemigatinib with or without history of cancer of unknown primary

接受培米替尼治疗的胆管癌患者(无论既往是否有原发性不明癌症病史)的经济和临床结局

Verma, Sumit; Hughes, Alejandro; Engel-Nitz, Nicole M; Steiger, Christina; Parasuraman, Shreekant; Javle, Milind; Lee, Sunyoung S; Saj, Fen; Blecker, Michael